Mortality in patients with cirrhosis: Prevalence, causes and predictive factors;Mortalite au cours des cirrhoses : Prevalence, causes et facteurs predictifs

Tunisie Medicale

Volumn 80, Issue 1, 2002, Pages 21-25

  Karoui, Sami ^a   Hamzaoui, Samir ^a   Sahli, Faouzia ^a   Matri, Samira ^a   Boubaker, Jalel ^a   Filali, Azza ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Cirrhosis; Mortality

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; FEMALE; FIBROSIS; HEALTH; HEPATITIS B; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FIBROSIS; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; WORLD HEALTH;

EID: 0036053647     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. D'AMICO G, MORABITO A, PAGLIARO L, MARUBINI E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 5:468-475.
2. BEN MAMI N, BEN ABDALLAH M, ZOUARI B. Les cirrhoses virales: profil épidémiologique clinique et évolutif. Etude multicentrique Tunisienne. Monographie. Ilème Congrès Maghrébin de Gastro-entérologie. Tunis, 28-29 Juin 1996.
3. CORRAO G, TORCHIO P, DE CARLI A, GALATOLA G, ARICO S, DI ORIO F. Effect of age, birth cohort and period of death on Italian liver cirrhosis mortality, 1972-1986. Int J Epidemiol 1993;22:475-482.
4. MAGLIOCHETTI N, TORCHIO P, CORRAO G, ARICO S, FAVILLI S. Prognostic factors for long term survival in cirrhotic patients after the first episode of liver decompensation. Ital J Gastroenterol Hepatol 1997 ; 29 : 38-45.
5. FATTOVICH G, GIUSTINA G, DEGOS F et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.
6. GENTILINI P, LAFFI G, LA VILLA G et al. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 1997;92:66-72.
7. PROPST A, PROPST T, ZANGERL G, OFNER D, JUDMAIER G, VOGEL W. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci 1995;40:1805-1815.
8. COLOMBO M. Hepatocellular carcinoma in cirrhotics. Semin Liver Dis 1993;13:374-383.
9. PINTO H, ABRANTES A, ESTEVES AV, ALMEIDA H, CORREIRA JP. Long term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am J Gastroenterol 1989;84:1239-1243.
10. CORDOBA J, BLEI AT. Treatment of hepatic encephalopathy. Am J Gastroenterol 1997;92:1429-1438.
11. CALES P. Histoire naturelle des varices oesophagiennes au cours de la cirrhose. Gastroenterol Clin Biol 1988 ;12:245-254.
12. DEL OLMO JA, PENA A, SERRA MA, WASSEL AH, BENAGES A, RODRIGO JM. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000;32:12-24.
13. AVGERINOS A NEVENS F, RAPTIS S, FEVERY J, and the ABOVE study group. Early administration of somatostatin and efficacy of sclerotherapy in acute esophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 1997;350:1495-1499.
14. BERNARD B, LEBREC D, MATHURIN P, OPOLON P, POYNARD T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 1997;26:312-324.
15. D'AMICO G, PAGLIARO L, BOSCH J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-354.
16. GARCIA-TSAO G. Spontaneous bacterial peritonitis. Gastroenterol Clin N Am 1992;21:257-275.
17. RIMOLA A, GARCIA-TSAO G, NAVASA M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000;32:142-153.
18. LLOVET JM, PLANAS R, MORILLAS R, QUER C, CABRE E. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993;88:388-392.
19. OKA H, KURIOKA N, KIM K, KANNO T, KUROKI T. Prospective study of early detection of HCC in patients with cirrhosis. Hepatology 1990;12:680-687.
20. COLOMBO M. Treatment of hepatocellular carcinoma. J Viral Hep 1997;4 (Suppl 1)125-130.
21. BAFFIS V, SHRIER I, SHERKER AH, SZILAGYI A. Use of Interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or C virus infection. Ann Intern Med 1999;131:696-701.
22. ALBERS I, HARTMANN H, BIRCHER J, CREUTZFELDT W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989;24:269-276.
23. ZOLI M, CORDIANI MR, MARCHESINI G et al. Prognosis indicators in compensated cirrhosis. Am J Gastroenterol 1991;86:1508-1513.